Uttar Pradesh Sugarcane Development Minister Laxmi Narayan Chaudhary announced that 90% of outstanding sugarcane dues to farmers have been cleared, with the remaining amount to be paid soon.

India's Income Tax Department warns taxpayers against making false claims for refunds, under-reporting income, or exaggerating deductions, emphasizing it's a punishable offence. Find out how to...

Foreign investors poured Rs 33,600 crore into Indian equities in July driven by policy reforms, strong earnings, and expectations of economic growth.

Mahindra Holidays & Resorts India Ltd expects 85% occupancy in FY25 driven by steady member demand and shorter holiday trends. CEO Manoj Bhat discusses occupancy, growth plans and the impact of...

Analysts say US Fed interest rate decision, Q1 earnings, global market trends, and FII activity will drive stock markets this week. Investors will also watch global oil prices and macroeconomic...

Central GST officers detected Rs 36,374 crore in fake ITC claims in FY24, a 51% increase from the previous year. The government is taking measures to combat this fraud.

Dr Reddy's Laboratories' biosimilar Rituximab, ITUXREDI, receives positive opinion from the European Medicines Agency (EMA), bringing it closer to launch in EU countries.

UltraTech Cement has confirmed that India Cements will remain a listed entity following its acquisition of a 32.72% stake. The open offer price is Rs 390 per share, and UltraTech intends to acquire...

Ceigall India's Rs 1,253 crore IPO opens on August 1 with a price band of Rs 380-401 per share. The infrastructure company's issue includes fresh issuance and OFS. Learn more.

BHIVE Workspace leases 42,000 sq ft office space in Bengaluru from Brigade Group, expanding its presence in the city's key business hubs. The new facility will support 1200+ seats, reflecting the...

Central GST officers detected Rs 36,374 crore in fake ITC claims in FY24, a 51% increase from the previous year. The government is taking measures to combat this fraud.

Dr Reddy's Laboratories' biosimilar Rituximab, ITUXREDI, receives positive opinion from the European Medicines Agency (EMA), bringing it closer to launch in EU countries.

UltraTech Cement has confirmed that India Cements will remain a listed entity following its acquisition of a 32.72% stake. The open offer price is Rs 390 per share, and UltraTech intends to acquire...

RBI Governor highlights digitalisation's impact on banking, emphasizing next-generation services, affordable finance, and challenges like cybersecurity and data privacy.

Ceigall India's Rs 1,253 crore IPO opens on August 1 with a price band of Rs 380-401 per share. The infrastructure company's issue includes fresh issuance and OFS. Learn more.